Clearmind Medicine’s VP of Business Development Presented at The Canadian Psychedelics
The CPA's Panel for physicians and medical professionals addressed "New Psychedelic Substances"TORONTO, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0, OTC Pink: CMNDF) (“Clearmind” or the "Company"), a…